Webform

Sign Up for Our Newsletter!

Stay connected with ZERO Prostate Cancer through our newsletter below:

Name
ZERO Prostate Cancer Webinar_banner

Genetics, the PROMISE Study, & Prostate Cancer: A Town Hall

Three black men

This webinar will present you with information on new treatments and help you understand your family risk through genetics. Join Rob Finch, Director of Urology Medical Affairs at Myriad Genetics, and Dr. Channing Paller, Associate Professor of Oncology and Urology at Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, as they discuss genetics in prostate cancer and the PROMISE Study Registry, a new research study led by physicians from Johns Hopkins University and University of Washington.

Learn more about Myriad Genetics’ options for genetic testing. 
Learn more about the Promise Registry Study.


Watch

Sponsored by

Myriad Genetics Logo ThePromiseStudyLogo

Contributor

Shelby Moneer Headshot
Shelby Moneer, Vice President, Patient Programs & Education

Shelby Moneer was the Vice President of Patient Programs & Education at ZERO Prostate Cancer until April 2025.

Share